Reductions in IκBε and changes in NF-κB activity during B lymphocyte differentiation

Journal of Immunology

Volumn 174, Issue 2, 2005, Pages 983-991

  Doerre, Stefan ^a   Mesires, Kristin Perkins ^a   Daley, Kylle M ^a   McCarty, Thomas ^b   Knoetig, Sonja ^b   Corley, Ronald B ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B; I KAPPA B ALPHA; I KAPPA B BETA; I KAPPA B EPSILON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR REL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CELL STIMULATION; COMPARATIVE STUDY; CONTROLLED STUDY; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SPLEEN CELL;

EID: 11844261534     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.2.983     Document Type: Article

References (62)

1. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141.
2. Baldwin, A. S., Jr. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649.
3. Ghosh, S., M. J. May, and E. B. Kopp. 1998. NF-κB and rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225.
4. Sha, W. C. 1998. Regulation of immune responses by NF-κB/Rel transcription factors. J. Exp. Med. 187:143.
5. Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18:621.
6. Stancovski, I., and D. Baltimore. 1997. NF-κB activation: the IκB kinase revealed? Cell 91:299.
7. May, M. J., and S. Ghosh. 1999. IκB kinases: kinsmen with different crafts. Science 284:271.
8. Israel, A. 2000. The IKK complex: an integrator of all signals that activate NF-κB? Trends Cell Biol. 10:129.
9. Sen, R., and D. Baltimore. 1986. Inducibility of κ immunoglobulin enhancer binding protein NF-κB by a posttranslational mechanism. Cell 47:921.
10. Sen, R., and D. Baltimore. 1986. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46:705.
11. Liou, H.-C., and D. Baltimore. 1993. Regulation of the NF-κB/rel transcription factor and IκB inhibitor system. Curr. Opin. Cell Biol. 5:477.
12. Miyamoto, S., M. J. Schmitt, and I. M. Verma. 1994. Qualitative changes in the subunit composition of κB-binding complexes during murine B-cell differentiation. Proc. Natl. Acad. Sci. USA 91:5056.
13. Grumont, R. J., and S. Gerondakis. 1994. The subunit composition of NF-κB complexes changes during B-cell development. Cell Growth Differ. 5:1321.
14. Francis, D. A., J. G. Karras, X.-y. Ke, R. Sen, and T. L. Rothstein. 1995. Induction of the transcription factors NF-κB, AP-1 and NF-AT during B cell stimulation through the CD40 receptor. Int. Immunol. 7:151.
15. Neumann, M., G. Wohlleben, S. Chuvpilo, B. Kistler, T. Wirth, E. Serfling, and A. Schimpl. 1996. CD40, but not lipopolysaccharide and anti-IgM stimulation of primary B lymphocytes, leads to persistent nuclear accumulation of RelB. J. Immunol. 157:4862.
16. Grilli, M., J. J. S. Chiu, and M. J. Lenardo. 1993. NF-κB and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1.
17. Kopp, E. B., and S. Ghosh. 1995. NF-κB and rel proteins in innate immunity. Adv. Immunol. 58:1.
18. Schauer, S. L., Z. Wang, G. E. Sonenshein, and T. L. Rothstein. 1996. Maintenance of nuclear factor-κB/Rel and c-myc expression during CD40 ligand rescue of WEHI 231 early B cells from receptor-mediated apoptosis through modulation of IκB proteins. J. Immunol. 157:81.
19. Lin, S. C., and J. Stavnezer. 1996. Activation of NF-κB/Rel by CD40 engagement induces the mouse germ line immunoglobulin Cγ1 promoter. Mol. Cell. Biol. 16:4591.
20. Iciek, L. A., S. A. Delphin, and J. Stavnezer. 1997. CD40 cross-linking induces Igε germline transcripts in B cells via activation of NF-κB: synergy with IL-4 induction. J. Immunol. 158:4769.
21. Franzoso, G., L. Carlson, L. Xing, L. Poljak, E. W. Shores, K. D. Brown, A. Leonardi, T. Tran, B. F. Boyce, and U. Siebenlist. 1997. Requirement for NF-κB in osteoclast and B-cell development. Genes Dev. 11:3482.
22. Gerondakis, S., M. Grossmann, Y. Nakamura, T. Fohl, and R. Grumont. 1999. Genetic approaches in mice to understand Rel/NF-κB and IκB function: transgenics and knockouts. Oncogene 18:6888.
23. Pohl, T., R. Gugasyan, R. J. Grumont, A. Strasser, D. Metcalf, D. Tarlinton, W. Sha, D. Baltimore, and S. Gerondakis. 2002. The combined absence of NF-κB1 and c-Rel reveals that overlapping roles for these transcription factors in the B cell lineage are restricted to the activation and function of mature cells. Proc. Natl. Acad. Sci. USA 99:4514.
24. Pasparakis, M., M. Schmidt-Supprian, and K. Rajewsky. 2002. IκB kinase signaling is essential for maintenance of mature B cells. J. Exp. Med. 196:743.
25. Schauer, S. L., R. E. Bellas, and G. E. Sonenshein. 1998. Dominant signals leading to inhibitor κB protein degradation mediate CD40 ligand rescue of WEHI231 immature B cells from receptor-mediated apoptosis. J. Immunol. 160:4398.
26. Phillips, R. J., and S. Ghosh. 1997. Regulation of IκBβ in WEHI 231 mature B cells. Mol. Cell. Biol. 17:4390.
27. Miyamoto, S., B. J. Seufzer, and S. D. Shumway. 1998. Novel IκBα proteolytic pathway in WEHI231 immature B cells. Mol. Cell. Biol. 18:19.
28. Fields, E. R., B. J. Seufzer, E. M. Oltz, and S. Miyamoto. 2000. A switch in distinct IκBα degradation mechanisms mediates constitutive NF-κB activation in mature B cells. J. Immunol. 164:4762.
29. Doerre, S., and R. B. Corley. 1999. Constitutive nuclear translocation of NF-κB in B cells in the absence of IκB degradation. J. Immunol. 163:267.
30. Simeonidis, S., S. Liang, G. Chen, and D. Thanos. 1997. Cloning and functional characterization of mouse IκBε. Proc. Natl. Acad. Sci. USA 94:14372.
31. Whiteside, S. T., J.-C. Epinat, N. R. Rice, and A. Israel. 1997. IκBε, a novel member of the IκB family, controls RelA and cRel NF-κB activity. EMBO J. 16:1413.
32. Rifkin, I. R., E. A. Leadbetter, B. C. Beaudette, C. Kiani, M. Monestier, M. J. Shlomchik, and A. Marshak-Rothstein. 2000. Immune complexes present in the sera of autoimmune mice activate rheumatoid factor B cells. J. Immunol. 165:1626.
33. Corley, R. B. 1982. The regulation of T cell growth: requirements for the activation and replication of antigen-specific interleukin 2 producing T cells. Immunobiology 163:63.
34. + B cell lymphoma. J. Immunol. 138:3075.
35. Rothstein, T. L., J. K. Wang, D. J. Panka, L. C. Foote, Z. Wang, B. Stanger, H. Cui, S. T. Ju, and A. Marshak-Rothstein. 1995. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374:163.
36. Hartley, J. W., T. N. Fredrickson, R. A. Yetter, M. Makino, and H. C. Morse 3d. 1989. Retrovirus-induced murine acquired immunodeficiency syndrome: natural history of infection and differing susceptibility of inbred mouse strains. J. Virol. 63:1223.
37. Brockman, J. A., D. C. Scherer, T. A. McKinsey, S. M. hall, X. Qi, W. Y. Lee, and D. W. Ballard. 1995. Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation. Mol. Cell. Biol. 15:2809.
38. Doerre, S., P. Sista, S.-C. Sun, D. W. Ballard, and W. C. Greene. 1993. The c-rel protooncogene product represses NF-κB p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 90:1023.
39. Chow, J. C., D. W. Young, D. T. Golenbock, W. J. Christ, and F. Gusovsky. 1999. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 274:10689.
40. Kunsch, C., and C. A. Rosen. 1993. NF-κB subunit-specific regulation of the interleukin-8 promoter. Mol. Cell. Biol. 13:6137.
41. Wechsler, A. S., M. C. Gordon, U. Dendorfer, and K. P. LeClair. 1994. Induction of IL-8 expression in T cells uses the CD28 costimulatory pathway. J. Immunol. 153:2515.
42. Schulte, R., G. A. Grassl, S. Preger, S. Fessele, C. A. Jacobi, M. Schaller, P. J. Nelson, and I. B. Autenrieth. 2000. Yersinia enterocolitica invasin protein triggers IL-8 production in epithelial cells via activation of Rel p65-p65 homodimers. FASEB J. 14:1471.
43. King, L. B., and R. B. Corley. 1990. Lipopolysaccharide and dexamethasone induce mouse mammary tumor proviral gene expression and differentiation in B lymphocytes through distinct regulatory pathways. Mol. Cell. Biol. 8:4211.
44. Lund, F. E., and R. B. Corley. 1991. Regulated expression of mouse mammary tumor proviral genes in cells of the B lineage. J. Exp. Med. 174:1439.
45. Lund, F. E., T. D. Randall, D. L. Woodland, and R. B. Corley. 1993. MHC class II limits the functional expression of endogenous superantigens in B cells. J. Immunol. 150:78.
46. Li, Z., and G. J. Nabel. 1997. A new member of the IκB protein family, IκBε, inhibits RelA (p65)-mediated NF-κB transcription. Mol. Cell. Biol. 17:6184.
47. - memory B cell compartment. J. Exp. Med. 191:1149.
48. Klinman, D. M., and H. C. Morse III. 1989. Characteristics of B cell proliferation and activation in murine AIDS. J. Immunol. 142:1144.
49. Morse, H. C. III, N. Giese, R. Morawetz, Y. Tang, R. Gazzinelli, W. K. Kim, S. Chattopadhyay, and J. W. Hartley. 1995. Cells and cytokines in the pathogenesis of MAIDS, a retrovirus-induced immunodeficiency syndrome of mice. Springer Semin. Immunopathol. 17:231.
50. + T cells are required for development of a murine retrovirus-induced immunodeficiency syndrome (MAIDS). J. Exp. Med. 168:623.
51. Yu, P., R. A. Morawetz, S. Chattopadhyay, M. Makino, T. Kishimoto, and H. Kikutani. 1999. CD40-deficient mice infected with the defective murine leukemia virus LP-BM5def do not develop murine AIDS but produce IgE and IgG1 in vivo. Eur. J. Immunol. 29:615.
52. Mosier, D. E., R. A. Yetter, and H. C. Morse III. 1985. Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice. J. Exp. Med. 161:766.
53. Grumont, R. J., I. B. Richardson, C. Gaff, and S. Gerondakis. 1993. rel/NF-κB nuclear complexes that bind κB sites in the murine c-rel promoter are required for constitutive c-rel transcription in B-cells. Cell Growth Differ. 4:731.
54. Ten, R. M., C. V. Paya, N. Israel, O. Le Bail, M. G. Mattei, J. L. Virelizier, P. Kourlsky, and A. Israel. 1992. The characterization of the promoter of the gene encoding the p50 subunit of NF-κB indicates that it participates in its own regulation. EMBO J. 11:195.
55. King, L. B., and R. B. Corley. 1989. Characterization of a pre-secretory phase in B cell differentiation. Proc. Natl. Acad. Sci. USA 86:2814.
56. Randall, T. D., F. E. Lund, J. W. Brewer, C. Aldridge, R. Wall, and R. B. Corley. 1993. IL-5 and IL-6 define two molecularly distinct pathways of B cell differentiation. Mol. Cell. Biol. 13:3929.
57. Hoffmann, A., A. Levchenko, M. L. Scott, and D. Baltimore. 2002. The IκB-NF-κB signaling module: temporal control and selective gene activation. Science 298:1241.
58. Memet, S., D. Laouini, J. C. Epinat, S. T. Whiteside, B. Goudeau, D. Philpott, S. Kayal, P. J. Sansonetti, P. Berche, J. Kanellopoulos, and A. Israel. 1999. IκBε-deficient mice: reduction of one T cell precursor subspecies and enhanced Ig isotype switching and cytokine synthesis. J. Immunol. 163:5994.
59. Shaffer, A. L., A. Rosenwald, E. M. Hurt, J. M. Giltnane, L. T. Lam, O. K. Pickeral, and L. M. Staudt. 2001. Signatures of the immune response. Immunity 15:375.
60. Thompson, J. E., R. J. Phillips, H. Erdjument-Bromage, P. Tempst, and S. Ghosh. 1995. IκB-β regulates the persistent response in a biphasic activation of NF-κB. Cell 80:573.
61. Pomerantz, J. L., and D. Baltimore. 2002. Two pathways to NF-κB. Mol. Cell 10:693.
62. Jain, A., C. A. Ma, S. Liu, M. Brown, J. Cohen, and W. Strober. 2001. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat. Immunol. 2:223.